Table 5.
Mean EDSS and KPS scores over time in asymptomatic and symptomatic PML patients
| Asymptomatic PML patients | Symptomatic PML patients | P value | |
|---|---|---|---|
| EDSS score | |||
| Pre-PML | 3.2 (n = 21) | 3.7 (n = 179) | 0.336 |
| At diagnosis | 4.1 (n = 11) | 5.4 (n = 193) | 0.038 |
| At 6 months | 4.9 (n = 11) | 6.6 (n = 87) | 0.007 |
| At 12 months | 5.1 (n = 6) | 6.5 (n = 59) | 0.169 |
| KPS score | |||
| Pre-PML | 84.0 (n = 10) | 81.1 (n = 97) | 0.475 |
| At diagnosis | 70.0 (n = 11) | 53.8 (n = 122) | 0.008 |
| At 6 months | 71.5 (n = 10) | 47.1 (n = 108) | <0.001 |
| At 12 months | 56.0 (n = 5) | 46.6 (n = 67) | 0.178 |
P value from Mann–Whitney–Wilcoxon test. EDSS, Expanded Disability Status Scale; KPS, Karnofsky Performance Scale; PML, progressive multifocal leukoencephalopathy.
Bold text indicates statistical significance.